Skip to content
healthcare.dev

SEROQUEL XR

NDC 61269-271, quetiapine, tablet, extended release, from H2-Pharma, LLC.

Product NDC
61269-271
Status
Listed
Labeler
H2-Pharma, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022047
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61269-271 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • QUETIAPINE FUMARATE150 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
61269-271-606126902716060 TABLET, EXTENDED RELEASE in 1 BOTTLE (61269-271-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ab959a35-d0ba-4f18-8f2e-6619d88b16e3

Use it

Look up 61269-271 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61269-271 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61269-271. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.